Page last updated: 2024-11-03

propranolol and Hepatitis E

propranolol has been researched along with Hepatitis E in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dumoulin, FL1
Liese, H1

Other Studies

1 other study available for propranolol and Hepatitis E

ArticleYear
Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger?
    BMJ case reports, 2012, Apr-23, Volume: 2012

    Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Carbimazole; Diagnosis, Differential; Drug Therapy,

2012